Previous studies demonstrated that inhibition of autophagy significantly enhanced the efficacy of many anti-cancer drugs [4–6], and in vitro models, synergistically increased the cytotoxicity of BTZ in myeloma [7] and liver cancer [8]. This evidence concerns the gene CASC3 and plasma cell myeloma.